Catalyst Wire Dossier Catalyst Wire Dossier

PALYNZIQ

PEGVALIASE-PQPZ · BioMarin Pharmaceutical Inc.
Drug timelines are a Plus or Pro feature.

14 regulatory and trial events tracked for PALYNZIQ, covering 2018-05-24 to 2026-04-03. Get the full timeline:

Most recent: Clinical Trial Update: Rapid Drug Desensitization Study in Adults Experiencing Hypersensitivity Reactions to Palynziq [Phase 4]

See pricing